Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Single-use Bioreactors Market Size Worth $7.76 Billion By 2028: Grand View Research, Inc.

This image opens in the lightbox

News provided by

Grand View Research, Inc.

18 Jan, 2022, 10:05 GMT

Share this article

Share toX

Share this article

Share toX

SAN FRANCISCO, Jan. 18, 2022 /PRNewswire/ -- The global single-use bioreactors market size is expected to reach USD 7.76 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 17.0% from 2021 to 2028. An increase in the demand for disposable bioreactors, coupled with the rapidly growing biopharmaceutical product demand, is leading to significant investments in this space. The outbreak of COVID-19 has created significant demand for single-use bioreactors as there is high demand for large-scale vaccine production across the globe.

Key Insights & Findings from the report:

  • Based on product, single-use bioreactor systems held the largest revenue share in 2020. Widespread acceptance of SUB systems and technological advancements have propelled the segment growth
  • In terms of type, stirred tank bioreactors led the market in 2020. They have high penetration across the end users, resulting in significant revenue generation throughout the forecast period
  • By type of cell, the mammalian cells segment captured the largest revenue share in 2020. Mammalian cell cultures play a crucial role in biopharmaceutical product manufacturing
  • On the basis of application, the research & development segment held the largest revenue share in 2020. The segment has high usage of disposable bioreactors are several biopharmaceutical companies and research institutes have switched to SUBs
  • The CROs and CMOs end-use segment dominated the market in 2020. Various CMOs are adding single-use system bioreactors to scale-up commercial manufacturing capacity. This has led to a number of CMOs becoming commercial product manufacturers. The COVID-19 pandemic has had a beneficial effect on contract research and contract manufacturing services. The segment is witnessing significant growth owing to the shift towards COVID-19 vaccine and therapeutic manufacturing
  • In 2020, the lab-scale production usage type segment accounted for the largest revenue share owing to a high number of research & development programs

Read 160 page market research report, "Single-use Bioreactors Market Size, Share & Trends Analysis Report By Product, By Type, By Type of Cell, By Molecule Type, By Application, By End Use, By Usage Type, By Region, And Segment Forecasts, 2021 - 2028", by Grand View Research

Continuous strategic initiatives undertaken by emerging as well as established market entities for the expansion of capabilities are expected to positively impact the market growth. For instance, in July 2021, Cytiva and Pall Corporation announced plans to expand their manufacturing capacity and services globally as they will invest over USD 300 million in single-use technologies as well as bioreactor bags for growing cells that are used to make syringe filters and customized medicines for research.

A rise in biopharmaceutical research & development also has a significant influence on the market growth. Applications of disposable bioreactors in COVID-19 vaccine manufacturing are fueling industrial growth. As the vaccine development process is complex, key companies are collaborating with research institutes on various fronts such as process development approaches, in turn, increasing the adoption of SUBs for R&D.

North America dominated the market in 2020 owing to the increasing adoption of SUBs, coupled with the presence of major biopharmaceutical and biotechnology industries. Asia Pacific is projected to expand at the fastest CAGR over the forecast period, with China being the largest country contributing to the market growth.

Market Segmentation:

Grand View Research has segmented the global single-use bioreactors market on the basis of product, type, type of cell, molecule type, application, end use, usage type, and region:

  • Single-use Bioreactors Product Outlook (Revenue, USD Million, 2017 - 2028)
    • Single-use bioreactor systems
      • Up to 10L
      • 11-100L
      • 101-500L
      • 501-1500L
      • Above 1500L
    • Single-use media bags
      • 2D Bags
      • 3D Bags
      • Others
    • Single-use Filtration Assemblies
      • Other Products
  • Single-use Bioreactors Type Outlook (Revenue, USD Million, 2017 - 2028)
    • Stirred-tank SUBs
    • Wave-induced SUBs
    • Bubble-column SUBs
    • Other SUBs
  • Single-use Bioreactors Type of Cell Outlook (Revenue, USD Million, 2017 - 2028)
    • Mammalian Cells
    • Bacterial Cells
    • Yeast Cells
    • Other Cells
  • Single-use Bioreactors Molecule Type Outlook (Revenue, USD Million, 2017 - 2028)
    • Monoclonal Antibodies
    • Vaccines
    • Gene Modified Cells
    • Stem Cells
    • Other Molecules
  • Single-use Bioreactors Application Outlook (Revenue, USD Million, 2017 - 2028)
    • Research and Development (R&D) or Process Development
    • Bioproduction
  • Single-use Bioreactors End-use Outlook (Revenue, USD Million, 2017 - 2028)
    • Pharmaceutical & Biopharmaceutical Companies
    • CROs & CMOs
    • Academic & Research Institutes
  • Single-use Bioreactors Usage Type Outlook (Revenue, USD Million, 2017 - 2028)
    • Lab-Scale Production
    • Pilot-Scale Production
    • Large-Scale Production
  • Single-use Bioreactors Regional Outlook (Revenue, USD Million, 2017 - 2028)
    • North America
      • U.S.
      • Canada
    • Europe
      • U.K.
      • Germany
      • France
      • Italy
      • Spain
    • Asia Pacific
      • Japan
      • China
      • India
      • South Korea
    • Latin America
      • Brazil
      • Mexico
    • Middle East & Africa
      • South Africa
      • Saudi Arabia

List of Key Players of Single-use Bioreactors Market

  • Sartorius Stedim Biotech
  • Thermo Fisher Scientific
  • Danaher
  • Merck KgaA
  • Celltainer Biotech BV
  • Getinge AB
  • Eppendorf AG
  • Cellexus
  • PBS Biotech Inc.
  • Distek Inc.
  • ABEC
  • Able Corporation & Biott Corporation
  • G&G Technologies Inc.
  • Solida Biotech GmbH
  • Satake Chemical Equipment Mfg., Ltd.
  • Stobbe Pharma GmbH
  • bbi-biotech GmbH

Check out more studies related to bioreactors and bioprocessing, published by Grand View Research:

  • Single-use Bioprocessing Market – The global single-use bioprocessing market size was valued at USD 15.8 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 16.0% from 2021 to 2028. Advantages offered by Single-Use Technology (SUT), such as significant reduction in capital cost and facility construction time, have proliferated the use of disposables in the bioprocessing industry.
  • Membrane Bioreactor Market – The global membrane bioreactor market size was estimated at USD 3.0 billion in 2020 and is expected to expand at a compounded annual growth rate (CAGR) of 9.9% from 2021 to 2028. Rising demand for membrane bioreactor (MBR) owing to its high-quality solid separation and low carbon footprint is expected to drive the market for membrane bioreactors over the forecast period.

Browse through Grand View Research's coverage of the Global Biotechnology Industry.

Gain access to Grand View Compass, our BI enabled intuitive market research database of 10,000+ reports

About Grand View Research

Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.

Contact:

Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc.
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com
Web: https://www.grandviewresearch.com
Follow Us: LinkedIn | Twitter 

Logo: https://mma.prnewswire.com/media/661327/Grand_View_Research_Logo.jpg

Modal title

Also from this source

Vineet Agarwal Joins Grand View Research as Investor and Board Member

Vineet Agarwal Joins Grand View Research as Investor and Board Member

We are pleased to announce that Vineet Agarwal, a seasoned business leader and investor with over 20 years of experience in strategy, research &...

Grand View Research's Latest Market Research Findings Predict Major Shifts in Flooring Market by 2030

Grand View Research's Latest Market Research Findings Predict Major Shifts in Flooring Market by 2030

The global flooring market size is estimated to reach USD 534.6 billion by 2030, registering a CAGR of 6.8% from 2025 to 2030, according to a new...

More Releases From This Source

Explore

Pharmaceuticals

Pharmaceuticals

Health Care & Hospitals

Health Care & Hospitals

Medical Pharmaceuticals

Medical Pharmaceuticals

Biotechnology

Biotechnology

News Releases in Similar Topics

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.